<  Retour au portail Polytechnique Montréal

Documents dont l'auteur est "Alameh, M."

Monter d'un niveau
Pour citer ou exporter [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Grouper par: Auteurs ou autrices | Date de publication | Sous-type de document | Aucun groupement
Aller à : 2011
Nombre de documents: 4

2011

Alameh, M., DeJesus, D., Benhamadi, M., Jean, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Chitosan nanoparticulate system for the delivery of siRNA targeting genome caretakers for the development of potential cancer therapies [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible

Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 14th Annual Meeting American Society of Gene and Cell Therapy, Seattle, WA, USA. Non disponible

Jean, M., Alameh, M., Daras, V., Lavertu, M., Thibault, M., Buschmann, M. D., & Merzouki, A. (mai 2011). Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of Type 2 Diabetes [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec, Canada. Non disponible

DeJesus, D., Alameh, M., Jean, M., Lascau, V., Buschmann, M. D., & Merzouki, A. (mai 2011). Therapeutic lowering of circulating ApoB in atherosclerotic mice by intravenous administration of chitosan-siRNA nanoparticles [Communication écrite]. 1st Meeting of Canadian Chapter of The Controlled Release Society, Montréal, Québec. Non disponible

Liste produite: Sun Dec 22 03:53:30 2024 EST.